About Emnar Pharma Private Limited
Data last updated:
Emnar Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2002PTC039653. Its GSTIN is 36AABCE2555Q1Z9 (Telangana). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹19.87 Cr. It was formerly known as Emmennar Bio-Tech Private Limited and Emmennar Biotech Private Limited. It is led by directors including Vamshidhar Reddy Kallem and Venkatarami Reddy.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No: A – 4 Mch No: 7 – 2 – A4 Industrial Estate Opp:Sanath Nagar Police Station, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹394.57 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹34.6 Cr (net margin 8.8%) and EBITDA of ₹68.62 Cr (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
The company has about 671 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Emnar Pharma and Emmennar. As per MCA filings, the company has open charges of ₹70.3 Cr and satisfied charges of ₹36.91 Cr on record. Court records list 20 cases involving the company, including 18 filed by the company; 7 cases are pending. The company has 12 deals on record (8 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹7.36 Cr; the latest was in March 2024. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Senores Pharmaceuticals Limited with revenue of ₹417.51 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2021, listing 82 overdue payments to 12 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emmennar.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No: A – 4 Mch No: 7 – 2 – A4 Industrial Estate Opp:Sanath Nagar Police Station, Hyderabad, Telangana, India – 500018
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emnar Pharma Private Limited
The main business activity of Emnar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emnar Pharma Private Limited FY 2024 filings available
Emnar Pharma Private Limited reported revenue of ₹394.57 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Emnar Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 1% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emnar Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹68.62 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34.6 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Emnar Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emnar Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emnar Pharma Private Limited
Emnar Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Limited | ₹417.51 Cr (FY 2025) | •••• | •••• | 92.0% | •••• | Ahmedabad, Gujarat, India |
| Themis Medicare Limited Listed | ₹410.18 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Vapi, Gujarat, India |
| Penam Laboratories Limited | ₹407.63 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | New Delhi, Delhi, India |
| Eisai Pharmaceuticals India Private Limited | ₹402.38 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Paravada, Andhra Pradesh, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Emnar Pharma Private Limited this company | ₹394.57 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Barentz India Private Limited | ₹392.83 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Astec Lifesciences Limited Listed | ₹386.93 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| Syschem (India) Limited Listed | ₹386.27 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Haryana, India |
| Tatva Chintan Pharma Chem Limited Listed | ₹385.03 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Ankleshwar, Gujarat, India |
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Emnar Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Emnar Pharma Private Limited
Emnar Pharma Private Limited is audited by Suryanarayana Reddy & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Suryanarayana Reddy & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Emnar Pharma Private Limited
Emnar Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vamshidhar Reddy Kallem | Director | 18 Nov 2013 | 12 Years 10 Months | Current |
| Venkatarami Reddy | Director | 01 Aug 2015 | 11 Years 2 Months | Current |
| Sudha Mundla Also directs: Virchow Petrochemical Private Limited, Andhra Organics Limited, Virchow Laboratories Limited and 1 more | Director | 23 Sep 2002 | 24 Years 0 Months | Current |
| Mundla Maha Vishnu Also directs: Virchow Petrochemical Private Limited, Andhra Organics Limited, Virchow Laboratories Limited and 5 more | Director | 01 Aug 2011 | 15 Years 2 Months | Current |
Ownership and Shareholding of Emnar Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emnar Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2015 | Citi Bank N.A. | ₹60 Cr | Open |
| 30 Aug 2010 | State Bank of India | ₹10.3 Cr | Open |
| 04 May 2015 | Citi Bank N.A. | ₹30 Cr | Satisfied |
| 01 Feb 2011 | Canara Bank | ₹8 Lakh | Satisfied |
| 26 Jul 2010 | Canara Bank | ₹6.4 Lakh | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Emnar Pharma Private Limited
Emnar Pharma Private Limited has 12 deals on record (8 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹7.36 Cr; the latest was in March 2024.
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jun 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2016 | Rights issue | ₹49.67 Cr | Investors: 4 individuals |
Full deal history
All 12 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Emnar Pharma Private Limited
Emnar Pharma Private Limited has 20 court cases on record: 18 filed by Emnar Pharma, 2 where it is another party. 7 cases are pending and 13 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 0 | 7 |
| High courts | 8 | 0 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed by the company against Fugen Laboratories Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Wockhardt Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Fugen Laboratories Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Vee Excel Drugs and Pharmaceuticals Private Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against Andhra Pradesh Industrial Infrastructure Corpn Ltd | Disposed |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Emnar Pharma Private Limited
Emnar Pharma Private Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 82 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sanjay Chemicals (India) Private Limited | •••• | •••• | •••• |
| Rd Industries | •••• | •••• | •••• |
| A S Moosani & Company | •••• | •••• | •••• |
| Piyush Pharmachem (India) Private Limited | •••• | •••• | •••• |
| Sanchem Sophin Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Emnar Pharma Private Limited
Emnar Pharma operates two associated brands: Emnar Pharma and Emmennar. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Emnar Pharma manufactures APIs, intermediates, and provides contract manufacturing services. | emnar.com | |
| R&D company focused on manufacturing of API products for multiple therapeutic areas | emmennar.com |
Employees and EPFO Compliance at Emnar Pharma Private Limited
Emnar Pharma Private Limited has a workforce of 671 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Emnar Pharma Private Limited
Emnar Pharma has 3 joint ventures. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Name History of Emnar Pharma Private Limited
Emnar Pharma has undergone 3 name changes throughout its history. The company was previously known as Emmennar Bio-Tech Private Limited, Emmennar Biotech Private Limited, and Emmennar Pharma Private Limited. The current legal name is Emnar Pharma Private Limited.
| Company Name | Status |
|---|---|
| Emnar Pharma Private Limited | Current |
| Emmennar Bio-Tech Private Limited | Previous |
| Emmennar Biotech Private Limited | Previous |
| Emmennar Pharma Private Limited | Previous |
CIN History of Emnar Pharma Private Limited
Emnar Pharma has one previous CIN (Corporate Identification Number): U24299AP2002PTC039653. The current CIN is U24299TG2002PTC039653, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299TG2002PTC039653 | Current |
| U24299AP2002PTC039653 | Previous |
Recent Activity on Emnar Pharma Private Limited
Emnar Pharma Private Limited has 10 board changes on record since 2002: 4 appointments and 6 cessations. The latest: Venkata Sri Ramanjaneya Sesh Kumar Kotha ceased to be Director on 02 Jun 2020.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Emnar Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emnar Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emnar Pharma Private Limited
Emnar Pharma has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCE2555Q1Z9 | Telangana | Active | 01 Jul 2017 |
| 36AABCE2555Q2Z8 | Telangana | Active | 06 Dec 2019 |
| 37AABCE2555Q1Z7 | Andhra Pradesh | Active | 01 Jul 2017 |
| 27AABCE2555Q1Z8 | Maharashtra | Active | 02 Aug 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emnar Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emnar Pharma Private Limited
Emnar Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 September 2002 (24+ years old) and is registered under CIN U24299TG2002PTC039653.
Emnar Pharma reported revenue of ₹394.57 Cr for FY 2024 (up 1% YoY).
Emnar Pharma has 4 current directors:
- Vamshidhar Reddy Kallem - Director
- Venkatarami Reddy - Director
- Sudha Mundla - Director
- Mundla Maha Vishnu - Director
Emnar Pharma reported a net profit of ₹34.6 Cr (net margin 8.8%) and EBITDA of ₹68.62 Cr (EBITDA margin 17.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emnar Pharma is 13% over three years and 7% over five years. In the latest year (FY 2024) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Emnar Pharma is 36AABCE2555Q1Z9, registered in Telangana. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 36AABCE2555Q2Z8 (Telangana), 37AABCE2555Q1Z7 (Andhra Pradesh), 27AABCE2555Q1Z8 (Maharashtra).
The CIN (Corporate Identification Number) of Emnar Pharma is U24299TG2002PTC039653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emnar Pharma has 20 court cases on record: 18 filed by the company. 7 are pending. Most are in the district courts.
Emnar Pharma was incorporated on 23 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
Emnar Pharma has 12 deals on record (8 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹7.36 Cr; the latest was in March 2024.
The peers of Emnar Pharma by revenue are Senores Pharmaceuticals Limited, Themis Medicare Limited, Penam Laboratories Limited, Eisai Pharmaceuticals India Private Limited, Gland Chemicals Pvt Ltd and 5 more, all in the Pharma industry (API Manufacturers).
Venkata Sri Ramanjaneya Sesh Kumar Kotha ceased to be Director on 02 Jun 2020. Lingala Durga Maheswara Reddy ceased to be Director on 28 Feb 2017. Venkatarami Reddy ceased to be Additional Director on 23 Sep 2015. Emnar Pharma has 10 board changes on record in total.